↓ Skip to main content

Clinical trial update on bispecific antibodies, antibody-drug conjugates, and antibody-containing regimens for acute lymphoblastic leukemia

Overview of attention for article published in Journal of Hematology & Oncology, February 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
4 X users
patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
66 Mendeley
Title
Clinical trial update on bispecific antibodies, antibody-drug conjugates, and antibody-containing regimens for acute lymphoblastic leukemia
Published in
Journal of Hematology & Oncology, February 2019
DOI 10.1186/s13045-019-0703-z
Pubmed ID
Authors

Delong Liu, Juanjuan Zhao, Yongping Song, Xiaofeng Luo, Ting Yang

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 66 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 18%
Student > Ph. D. Student 10 15%
Student > Bachelor 5 8%
Student > Master 5 8%
Student > Doctoral Student 4 6%
Other 8 12%
Unknown 22 33%
Readers by discipline Count As %
Medicine and Dentistry 14 21%
Biochemistry, Genetics and Molecular Biology 10 15%
Pharmacology, Toxicology and Pharmaceutical Science 8 12%
Agricultural and Biological Sciences 3 5%
Chemistry 3 5%
Other 5 8%
Unknown 23 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 February 2023.
All research outputs
#4,779,374
of 23,884,161 outputs
Outputs from Journal of Hematology & Oncology
#379
of 1,237 outputs
Outputs of similar age
#108,457
of 445,676 outputs
Outputs of similar age from Journal of Hematology & Oncology
#12
of 27 outputs
Altmetric has tracked 23,884,161 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,237 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,676 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.